Ligand validation:5XJF

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5XJF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XJF_NAG_C_1001	43%	44%	0.191	0.913	0.83	1.32	-	2	0	0	100%	0.9333
5ML9_NAG_A_201	74%	90%	0.127	0.956	0.21	0.39	-	-	0	0	100%	0.9333
7URU_NAG_C_1002	72%	76%	0.124	0.947	0.55	0.41	-	-	1	0	100%	0.9333
5MN2_NAG_B_401	43%	86%	0.19	0.912	0.2	0.51	-	-	0	0	100%	0.9333
5VU0_NAG_C_201	25%	5%	0.161	0.834	1.78	3.37	3	6	0	0	80%	0.8
7SEG_NAG_C_201	12%	90%	0.212	0.745	0.2	0.39	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.